Accuracy of Contrast-Enhanced Ultrasound for Liver Cancer After Treatment
Author Information
Author(s): McGillen Kathryn L., Pryor William Watkins 3rd, Yee Nelson S., Zhu Junjia, Krok Karen L., Waybill Peter N.
Primary Institution: Penn State Health Milton S. Hershey Medical Center
Hypothesis
Is contrast-enhanced ultrasound (CEUS) as effective as CT and MRI for diagnosing hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE)?
Conclusion
CEUS is comparable to CT/MRI in evaluating residual liver cancer after TACE.
Supporting Evidence
- CEUS identified 19 cases of residual tumor, while CT/MRI identified 17.
- Both CEUS and CT/MRI identified five portal vein thrombi.
- CEUS had a sensitivity of 94.7% and specificity of 92.9% for identifying tumors.
Takeaway
Doctors used a special ultrasound to check for liver cancer after treatment, and it worked just as well as other scans.
Methodology
This was a prospective pilot study comparing CEUS and CT/MRI in patients with HCC after TACE.
Potential Biases
There may be a learning curve for interpreting CEUS images, which could affect results.
Limitations
The study had a small sample size and limited statistical power.
Participant Demographics
The study included 26 patients (19 male, 7 female) with a mean age of 66.6 years, primarily white (84.6%), with common risk factors including hepatitis C.
Statistical Information
P-Value
0.617
Statistical Significance
p = 0.617
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website